For 2025 on a consolidated basis, insurance revenue was KRW 2,175.5bn, operating profit KRW 375.7bn and net profit attributable to owners KRW 268.4bn, up 4.2%, 34.3% and 25.9% respectively from 2024 (KRW 2,088.3bn, KRW 279.7bn, KRW 213.1bn).
Because profit grew far faster than revenue, the operating margin rose from roughly 13.4% in 2024 to about 17.3% in 2025.
One caveat on earnings quality: Korea Investors Service noted in its June 2026 report that 2025 insurance profit of KRW 251.1bn, up 72% year on year, included a one-off cost reversal following litigation over claim payments. The quarterly path illustrates the point.
Fourth quarter 2025 delivered KRW 554.6bn of insurance revenue with KRW 182.9bn of operating profit, a margin of roughly 33.0%, and KRW 121.7bn of net profit, well apart from other quarters running margins in the 14-16% range.
First quarter 2026 posted the largest insurance revenue of the five reported quarters at KRW 652.4bn, yet operating profit was KRW 93.5bn and net profit KRW 57.4bn, reflecting how retrospective premium settlement on jeonse-related products that had generated heavy past claims lifted insurance profit by about KRW 59.8bn year on year to KRW 62.5bn, flowing through revenue and profit differently.
Second quarter 2026 showed insurance revenue of KRW 545.7bn, down 3.0% from KRW 562.8bn a year earlier, with operating profit of KRW 87.0bn, up 2.9%, and net profit of KRW 66.1bn, up 0.9%, taking the operating margin to about 15.9%.
Net profit attributable to owners over the four quarters from 3Q25 to 2Q26 totals KRW 307.1bn. Cash flow and the balance sheet are steady, with 2025 operating cash flow of KRW 387.2bn versus KRW 315.0bn in 2024, total equity of KRW 5,195.2bn and a debt-to-equity ratio of 81.1% against 80.3% in 2024.
Still, much of the profit recovery stems from lower loss ratios and premium settlements, so the recurring scale of those settlements and the pace of subrogation recovery will shape the earnings path from here.